MedTrace Logo

Exploratory Study of Efficacy on Selected Natural Extracts Reducing Post Prandial Blood Glucose Response

NCT04258501 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2020-02-06

No results posted yet for this study

Summary

Randomized, balanced, incomplete block design exploratory study of efficacy, with 8 active treatments (4 treatments per subject; 35 or 37 subjects per treatment) compared to a reference treatment (all 72 subjects).

Conditions

  • Blood Glucose

Interventions

OTHER

Mulberry fruit

OTHER

Mulberry leaf

OTHER

White bean

OTHER

Apple

OTHER

Elderberry

OTHER

Turmeric

OTHER

Rice porridge

Sponsors & Collaborators

  • Lambda Therapeutic Research Ltd.

    collaborator INDUSTRY

  • Unilever R&D

    lead INDUSTRY

Principal Investigators

  • David Mela, Dr. · Unilever R&D Vlaardingen (retired)

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-11-24
Primary Completion
2012-01-06
Completion
2012-01-06

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04258501 on ClinicalTrials.gov